Literature DB >> 8278686

The macula densa mechanism for control of renin secretion.

J N Lorenz1, S G Greenberg, J P Briggs.   

Abstract

Many questions remain concerning the precise mechanism by which the luminal signal for renin secretion is transmitted from the MD to the JG granular cell. It appears likely that a number of pathways may participate in MD-mediated changes in renin release, some of the agents serving to modulate release, others participating directly in signal transmission. Collectively, the current information suggests a transmission pathway that involves several steps. First, changes occurring in MD NaCl transport, which result directly from alterations in luminal NaCl concentration, act to initiate the response. Second, conveyance of this signal to the extraglomerular mesangial cells via a change in the ionic environment of the EGM field and/or a paracrine factor produced by the MD (perhaps NO) appear likely to be the next step. The subsequent steps probably include changes in prostaglandin production by the EGM, and possible participation of other paracrine factors produced by both endothelial and extraglomerular mesangial cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8278686

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  8 in total

1.  A new cardiac MASTer switch for the renin-angiotensin system.

Authors:  Thu H Le; Thomas M Coffman
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

2.  Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.

Authors:  R C Harris; J A McKanna; Y Akai; H R Jacobson; R N Dubois; M D Breyer
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

3.  Angiotensin II attenuates renal cortical cyclooxygenase-2 expression.

Authors:  H F Cheng; J L Wang; M Z Zhang; Y Miyazaki; I Ichikawa; J A McKanna; R C Harris
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 4.  Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms.

Authors:  Rodger Loutzenhiser; Karen Griffin; Geoffrey Williamson; Anil Bidani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-05       Impact factor: 3.619

Review 5.  Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.

Authors:  Gary Noroian; David Clive
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Increased renal renin content in mice lacking the Na+/H+ exchanger NHE2.

Authors:  Fiona Hanner; Régine Chambrey; Soline Bourgeois; Elliott Meer; István Mucsi; László Rosivall; Gary E Shull; John N Lorenz; Dominique Eladari; János Peti-Peterdi
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-20

Review 7.  Prostanoids and blood pressure: which way is up?

Authors:  Helene Francois; Thomas M Coffman
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 8.  Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis.

Authors:  Helmut Schmidt; Barry G Woodcock; Gerd Geisslinger
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.